Skip to main content
Algernon Health Inc. logo

Algernon Health Inc. — Investor Relations & Filings

Ticker · AGN CSE Human health and social work activities
Open in API
Filings indexed 308 across all filing types
Latest filing 2025-12-30 Regulatory Filings
Country CA Canada
Listing CSE AGN

About Algernon Health Inc.

https://www.algernonhealth.com/

Algernon Health Inc. is a healthcare company focused on the provision of advanced diagnostic services, primarily through the establishment of medical clinics specializing in Alzheimer's disease. A key offering is the utilization of brain-optimized Positron Emission Tomography (PET) scanning technology for screening and imaging within a planned network of North American facilities. The company maintains a clinical-stage drug development and repurposing division, which investigates existing, approved drugs for new therapeutic applications targeting unmet global medical needs.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-502F1, which is a regulatory filing used by reporting issuers in Ontario to calculate and pay participation fees to the Ontario Securities Commission (OSC). It is a specific regulatory compliance document rather than a financial report, earnings release, or management report. Since it does not fit into the specific categories like 10-K, IR, or ER, and is a formal regulatory submission, it is best classified under the fallback category for regulatory filings.
2025-12-30 English
Audited annual financial statements – English.pdf
Annual Report Classification · 1% confidence The document is a comprehensive set of consolidated financial statements for Algernon Health Inc. for the years ended August 31, 2025 and 2024. It includes an independent auditor's report, consolidated statements of financial position, statements of loss and comprehensive loss, and statements of cash flows. This content constitutes a formal annual financial report, which falls under the '10-K' category as it represents the official yearly financial performance reporting. FY 2025
2025-12-30 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the closing of a third tranche of a private placement financing and an increase in the total financing amount. This falls directly under the definition of 'Capital/Financing Update' (CAP), which covers updates on company fundraising and financing activities.
2025-12-24 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a standard Canadian regulatory filing used by issuers to report the distribution of securities that are exempt from the prospectus requirement. This document details the issuer's information, the nature of the securities distributed (units consisting of common shares and warrants), and the exemption relied upon. It is a specific regulatory filing required by Canadian securities commissions and does not fit into categories like Annual Reports, Earnings Releases, or Investor Presentations. Therefore, it is classified as a Regulatory Filing.
2025-12-08 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing a strategic business and investment agreement between Algernon Health and American Molecular Imaging. It details a $500,000 investment, an exclusive service contract, and mentions a private placement. Since it describes a specific corporate financing and strategic partnership event rather than a recurring financial report or a regulatory filing, it falls under the 'Capital/Financing Update' category.
2025-11-24 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a standard regulatory filing required by Canadian securities commissions when an issuer distributes securities under a prospectus exemption. This document details the issuer (Algernon Health Inc.), the nature of the distribution, the securities involved, and the exemptions relied upon. It does not fit into categories like Annual Reports, Earnings Releases, or Investor Presentations. As it is a specific regulatory form filed with authorities, it falls under the 'Regulatory Filings' category.
2025-11-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.